Vascular Biogenics' shares had been trading for six days when its IPO was canceled and all those trades undone. The reason: A condition outlined in its prospectus wasn't met.
via WSJ.com: Markets http://ift.tt/1oPNy4k
via WSJ.com: Markets http://ift.tt/1oPNy4k
Nessun commento:
Posta un commento